General Pharmacology — MCQs

Q: Therapeutic drug monitoring is done for all of the following drugs except?

Diclofenac. **Explanation:** Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring drug concentrations in the blood to maintain a constant concentration within a specific **therapeutic window**. It is indicated for drugs with a narrow therapeutic index, high inter-individual pharmacokinetic variability, or a direct correlation between plasma levels and clinical effects/toxicity. **Why Diclofenac is the correct answer:** Diclofenac is a Non-Steroidal Anti-Inflammatory Drug (NSAID) with a **wide therapeutic index**. Its clinical effect (analgesia and anti-inflammatory action) can be easily monitored by clinical response (reduction in pain or swelling). Furthermore, there is no established correlation between its plasma concentration and its efficacy or toxicity profile, making TDM unnecessary and impractical. **Analysis of incorrect options:** * **Phenytoin:** An antiepileptic with **zero-order (saturated) kinetics** at therapeutic doses. Small dose increases can lead to disproportionately large increases in plasma levels, causing toxicity (e.g., ataxia, nystagmus). TDM is mandatory. * **Tacrolimus & Cyclosporine:** Both are **calcineurin inhibitors** (immunosuppressants) used in organ transplants. They have a very narrow therapeutic window; low levels lead to graft rejection, while high levels cause significant nephrotoxicity and neurotoxicity. TDM is standard of care for these agents. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for TDM drugs:** "**L**ithium, **I**mmunosuppressants (Cyclosporine/Tacrolimus), **T**ricyclic Antidepressants, **A**nti-epileptics (Phenytoin/Valproate), **D**igoxin, **A**minoglycosides, **T**heophylline" (**LITA DAT**). * **Drugs NOT requiring TDM:** Drugs with easily measurable physiological markers (e.g., Warfarin via PT/INR, Antihypertensives via Blood Pressure, Insulin via Blood Glucose). * **Phenytoin** is a classic "TDM favorite" in exams due to its non-linear pharmacokinetics.

Q: Which of the following therapeutic index (T.I.) values represents the greatest safety profile for a drug?

1,000. ### Explanation **Concept Overview** The **Therapeutic Index (T.I.)** is a quantitative measurement of a drug's relative safety [1]. It is defined as the ratio of the dose that produces toxicity to the dose that produces a clinically desired effective response. Mathematically, it is expressed as: **T.I. = TD₅₀ / ED₅₀** (or LD₅₀ / ED₅₀ in animal studies) [1] * **TD₅₀:** Toxic dose in 50% of the population. * **ED₅₀:** Effective dose in 50% of the population. **Why Option B is Correct** The safety of a drug is **directly proportional** to its Therapeutic Index [1]. A higher T.I. indicates a wider "margin of safety," meaning there is a large gap between the dose required for efficacy and the dose that causes toxicity [2]. Among the given options, **1,000** is the highest value, representing the widest margin and, therefore, the greatest safety profile. **Analysis of Incorrect Options** * **Options A (100) and C (500):** While these values represent relatively safe drugs, they are less safe than a drug with a T.I. of 1,000. * **Option D (2):** This represents a **Narrow Therapeutic Index (NTI)** drug. Such drugs are inherently risky because a small increase in dose or a minor change in blood concentration can lead to severe toxicity. **NEET-PG High-Yield Pearls** * **Narrow Therapeutic Index Drugs (Mnemonic: "W-A-R-F-I-N-G-L-E-T"):** **W**arfarin, **A**minoglycosides/Amiodarone, **R**ifampicin, **F**enytoin (Phenytoin), **I**nsulin, **N**eostigmine, **G**lycosides (Digoxin), **L**ithium, **E**thosuximide/Enalapril, **T**heophylline/Tricyclic Antidepressants. * **Clinical Monitoring:** Drugs with a low T.I. often require **Therapeutic Drug Monitoring (TDM)** to ensure safety and efficacy [3]. * **Penicillin** is a classic example of a drug with a very high T.I., making it remarkably safe even at high doses.

Q: Which of the following is an example of physiological antagonism?

Prostacycline–Thromboxane. ### Explanation **Physiological (Functional) Antagonism** occurs when two drugs act on **different receptors** or through different mechanisms, but produce **opposing physiological effects** on the same biological system. **1. Why Option B is Correct:** * **Prostacyclin (PGI2)** acts on IP receptors to cause vasodilation and inhibition of platelet aggregation. * **Thromboxane A2 (TXA2)** acts on TP receptors to cause vasoconstriction and promotion of platelet aggregation. * Since they produce opposite effects using distinct pathways/receptors, they are classic examples of physiological antagonists. **2. Analysis of Incorrect Options:** * **A. Heparin–Protamine:** This is an example of **Chemical Antagonism**. Protamine (strongly basic) reacts chemically with Heparin (strongly acidic) to form an inactive complex, neutralizing its effect without involving receptors. * **C. Adrenaline–Phenoxybenzamine:** This is **Pharmacological Antagonism**. Phenoxybenzamine is a non-competitive antagonist that binds to the same alpha-receptors that Adrenaline targets. * **D. Physostigmine–Acetylcholine:** This is **Synergism/Potentiation**. Physostigmine inhibits the enzyme acetylcholinesterase, preventing the breakdown of Acetylcholine, thereby increasing its concentration and effect. **3. NEET-PG High-Yield Pearls:** * **Most Common Example:** The most frequently asked example of physiological antagonism is **Adrenaline vs. Histamine** on bronchial smooth muscle (Adrenaline causes bronchodilation via $\beta_2$ receptors; Histamine causes bronchoconstriction via $H_1$ receptors). * **Glucagon vs. Insulin:** Another high-yield example (Glucagon increases blood sugar; Insulin decreases it). * **Key Distinction:** Unlike competitive antagonism, physiological antagonism cannot be completely overcome by increasing the dose of the agonist because the drugs work on entirely different systems.

Q: Sibutramine belongs to which group of drugs according to its indication of use?

Anti-Obesity. ### Explanation **Correct Answer: C. Anti-Obesity** **Mechanism of Action:** Sibutramine is a centrally acting drug used for weight management. It functions as a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. By inhibiting the reuptake of these neurotransmitters in the hypothalamus, it enhances satiety (feeling of fullness) and increases metabolic rate (thermogenesis), thereby reducing food intake and promoting weight loss. **Analysis of Incorrect Options:** * **A. Antipsychotic:** Antipsychotics (like Haloperidol or Clozapine) primarily target Dopamine ($D_2$) receptors. Interestingly, many antipsychotics cause weight *gain* as a side effect, the opposite of Sibutramine’s effect. * **B. Antihypertensive:** Sibutramine is actually **contraindicated** in patients with uncontrolled hypertension because its sympathomimetic effects (increased norepinephrine) can elevate blood pressure and heart rate. * **D. Anti-Diabetic:** While weight loss can improve glycemic control in Type 2 Diabetes, Sibutramine does not have a direct mechanism for lowering blood glucose (unlike Metformin or GLP-1 agonists). **High-Yield Clinical Pearls for NEET-PG:** * **Regulatory Status:** Sibutramine was **withdrawn** from the market in many countries (including India and the USA) due to the **SCOUT trial**, which showed an increased risk of major adverse cardiovascular events (MI and stroke). * **Drug Class:** It is chemically related to amphetamines but does not have the same high potential for abuse. * **Other Anti-Obesity Drugs to Remember:** * **Orlistat:** Gastric and pancreatic lipase inhibitor (prevents fat absorption). * **Lorcaserin:** $5HT_{2C}$ receptor agonist (withdrawn due to cancer risk). * **Liraglutide:** GLP-1 receptor agonist (injectable). * **Phentermine + Topiramate:** Combination therapy.

Q: Which of the following drugs can cause malignant hyperthermia?

All the above. **Explanation:** **Malignant Hyperthermia (MH)** is a rare, life-threatening pharmacogenetic disorder of skeletal muscle characterized by a hypermetabolic state. It is primarily caused by an inherited mutation in the **Ryanodine Receptor (RYR1)** or the dihydropyridine receptor, leading to excessive calcium release from the sarcoplasmic reticulum. **Why "All the above" is correct:** * **Succinylcholine (Option A):** This depolarizing neuromuscular blocker is a classic "triggering agent." It causes persistent depolarization, which, in susceptible individuals, leads to massive calcium release and muscle rigidity. * **Halothane (Option B):** All volatile inhalational anesthetics (Halothane, Isoflurane, Sevoflurane, etc.) are potent triggers of MH. Halothane is historically the most frequently implicated agent in textbooks. * **Lidocaine (Option C):** While modern amide locals are generally considered safe, classic pharmacological teaching and older literature have associated high doses of amide local anesthetics with triggering or exacerbating MH. In the context of this specific MCQ, it is included as a potential trigger alongside the primary culprits. **Clinical Pearls for NEET-PG:** 1. **Early Sign:** The earliest and most reliable sign of MH is an **increase in End-Tidal CO2 (ETCO2)**, followed by tachycardia and masseter muscle rigidity. 2. **Late Sign:** Hyperthermia (fever) is often a late sign but can be extreme (>42°C). 3. **Drug of Choice:** **Dantrolene** is the specific antidote. It works by blocking the Ryanodine receptors (RYR1), thereby inhibiting calcium release. 4. **Safe Agents:** Safe alternatives for MH-susceptible patients include Propofol, Etomidate, Ketamine, and Ester-type local anesthetics.

Q: Zero order kinetics is followed by all of the following drugs EXCEPT?

Barbiturates. The core concept here is the difference between **First-order** and **Zero-order kinetics**. Most drugs follow first-order kinetics, where a constant *fraction* of the drug is eliminated per unit time [1]. In contrast, zero-order kinetics occurs when the elimination processes (usually enzymes) become saturated; a constant *amount* of the drug is eliminated regardless of its plasma concentration [1]. **1. Why Barbiturates is the correct answer:** Most **Barbiturates** (like Phenobarbital) follow **First-order kinetics**. Their rate of elimination is proportional to the plasma concentration [1]. While very high doses can lead to saturation, they are classically categorized as first-order drugs in standard pharmacological teaching. **2. Analysis of Incorrect Options (Drugs following Zero-order kinetics):** * **Phenytoin (A):** It follows zero-order kinetics at therapeutic or high concentrations (Michaelis-Menten kinetics). Small dose increases can lead to disproportionately large increases in plasma levels, causing toxicity [1]. * **Alcohol/Ethanol (C):** It is the classic example of zero-order kinetics. The enzyme alcohol dehydrogenase is saturated even at low social drinking levels [1]. * **Theophylline (D):** At higher therapeutic ranges, theophylline's metabolism becomes saturated, shifting from first-order to zero-order kinetics. **3. High-Yield Clinical Pearls for NEET-PG:** To remember the drugs following Zero-order kinetics, use the mnemonic **"WATT"** or **"Zero WATTS"**: * **W** – Warfarin (at very high doses) * **A** – Alcohol / Aspirin (at high doses) * **T** – Theophylline * **T** – Tolbutamide * **S** – Salicylates / **S**-Phenytoin **Key distinction:** Zero-order kinetics is also called **"Capacity-limited elimination"** or **"Non-linear kinetics."** In these drugs, the half-life ($t_{1/2}$) is not constant; it increases as the dose increases [1].

Q: All of the following are inducers of the microsomal enzyme system except?

Ticlopidine. ### Explanation The microsomal enzyme system, primarily the **Cytochrome P450 (CYP450)** family in the liver, is responsible for the metabolism of many drugs. **Enzyme Inducers** increase the synthesis of these enzymes, leading to faster metabolism and decreased plasma concentrations of co-administered drugs. **Why Ticlopidine is the Correct Answer:** Ticlopidine is an antiplatelet drug that acts as a **microsomal enzyme inhibitor**, specifically inhibiting CYP2C19. Unlike inducers, inhibitors decrease enzyme activity, which can lead to toxic levels of other drugs (e.g., phenytoin or theophylline) if administered concurrently. **Analysis of Incorrect Options (Inducers):** * **A. Carbamazepine:** A potent inducer of CYP3A4. It is unique because it is an **auto-inducer**, meaning it induces its own metabolism over time. * **B. Phenytoin:** A classic broad-spectrum inducer that affects multiple CYP isoforms, often leading to significant drug-drug interactions (e.g., reducing the efficacy of oral contraceptives). * **C. Phenobarbitone:** One of the most powerful known inducers. It increases the synthesis of glucuronyl transferase and CYP enzymes, and is clinically used in neonatal jaundice to accelerate bilirubin conjugation. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Mnemonic for Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**iclopidine/Terfenadine, **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**on-DHP CCBs (Verapamil/Diltiazem), **K**etoconazole (and other Azoles). * **Chronic Alcoholism** induces enzymes, whereas **Acute Alcohol intake** inhibits them. * **St. John’s Wort** is a notable herbal enzyme inducer often tested in exams.

Q: Which drug schedule requires medical supervision for its administration?

Schedule G. The correct answer is **Schedule G**. In the context of the Drugs and Cosmetics Act (1940), different schedules categorize drugs based on their storage, sale, and administration requirements [1, 2]. **Why Schedule G is correct:** Schedule G contains a list of drugs that are mostly used for chronic conditions and require **medical supervision** during their administration. These drugs are not necessarily "dangerous" in the same way as narcotics, but they carry risks that necessitate monitoring by a physician. Labels for these drugs must carry the mandatory warning: "Caution: It is dangerous to take this preparation except under medical supervision." Common examples include Metformin, Glibenclamide, and various antihistamines. **Analysis of Incorrect Options:** * **Schedule H:** These are **Prescription Drugs**. They can only be sold by retail on the prescription of a Registered Medical Practitioner (RMP) [1, 2]. While they require a prescription, they do not specifically mandate "medical supervision" during the actual course of administration. * **Schedule M:** This relates to **Good Manufacturing Practices (GMP)**. It outlines the requirements for factory premises, waste disposal, and equipment for pharmaceutical companies. * **Schedule P:** This specifies the **Life period (expiry date)** and storage conditions for various drugs. **High-Yield Clinical Pearls for NEET-PG:** * **Schedule X:** Includes Psychotropic drugs and Narcotics (e.g., Ketamine, Amphetamines). These require a double-copy prescription, and the pharmacist must preserve the prescription for 2 years [1, 2]. * **Schedule Y:** Guidelines for **Clinical Trials** and import/manufacture of new drugs. * **Schedule K:** List of drugs exempted from certain provisions of manufacture.

General Pharmacology Indian Medical PG Practice Questions and MCQs

Question 1: Tachyphylaxis is seen after the use of which of the following drugs?

A. Tamoxifen
B. Ephedrine (Correct Answer)
C. Morphine
D. Chlorpromazine

Explanation: **Explanation:** **Tachyphylaxis** is defined as a rapid decrease in response to a drug after repeated administration over a short period. Unlike tolerance, which develops slowly, tachyphylaxis occurs quickly and cannot be overcome by simply increasing the dose. **Why Ephedrine is the Correct Answer:** Ephedrine is a classic example of a drug that exhibits tachyphylaxis. It acts primarily as an **indirect-acting sympathomimetic**, meaning it works by displacing norepinephrine (NE) from storage vesicles in the nerve endings. With repeated, frequent administration, the available stores of NE become depleted. Once the "pool" of neurotransmitters is exhausted, further doses of ephedrine produce little to no pharmacological effect until the nerve endings have time to synthesize and restock NE. **Analysis of Incorrect Options:** * **Tamoxifen (A):** This is a Selective Estrogen Receptor Modulator (SERM). It does not typically show rapid desensitization or tachyphylaxis. * **Morphine (C):** Morphine leads to **Tolerance**, not tachyphylaxis. Tolerance to opioids develops over days or weeks due to receptor downregulation and internalisation, requiring higher doses for the same analgesic effect. * **Chlorpromazine (D):** This is a typical antipsychotic. While patients may develop tolerance to its sedative effects, it does not exhibit the rapid acute waning of effect characteristic of tachyphylaxis. **High-Yield Clinical Pearls for NEET-PG:** * **Common drugs showing Tachyphylaxis:** **T**yramine, **E**phedrine, **A**mphetamine, **N**icotine, **N**itroglycerin, and **D**econgestants (e.g., Xylometazoline). (Mnemonic: **T**ea **E**n**A** **N**i**N**D). * **Mechanism:** Usually due to depletion of endogenous neurotransmitters or rapid receptor phosphorylation/internalization. * **Nitrates:** Tachyphylaxis (often called "nitrate tolerance") occurs due to the depletion of free sulfhydryl (-SH) groups required for NO release; hence, a "nitrate-free interval" is recommended.

Question 2: Therapeutic drug monitoring is done for all of the following drugs except?

A. Phenytoin
B. Diclofenac (Correct Answer)
C. Tacrolimus
D. Cyclosporine

Explanation: **Explanation:** Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring drug concentrations in the blood to maintain a constant concentration within a specific **therapeutic window**. It is indicated for drugs with a narrow therapeutic index, high inter-individual pharmacokinetic variability, or a direct correlation between plasma levels and clinical effects/toxicity. **Why Diclofenac is the correct answer:** Diclofenac is a Non-Steroidal Anti-Inflammatory Drug (NSAID) with a **wide therapeutic index**. Its clinical effect (analgesia and anti-inflammatory action) can be easily monitored by clinical response (reduction in pain or swelling). Furthermore, there is no established correlation between its plasma concentration and its efficacy or toxicity profile, making TDM unnecessary and impractical. **Analysis of incorrect options:** * **Phenytoin:** An antiepileptic with **zero-order (saturated) kinetics** at therapeutic doses. Small dose increases can lead to disproportionately large increases in plasma levels, causing toxicity (e.g., ataxia, nystagmus). TDM is mandatory. * **Tacrolimus & Cyclosporine:** Both are **calcineurin inhibitors** (immunosuppressants) used in organ transplants. They have a very narrow therapeutic window; low levels lead to graft rejection, while high levels cause significant nephrotoxicity and neurotoxicity. TDM is standard of care for these agents. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for TDM drugs:** "**L**ithium, **I**mmunosuppressants (Cyclosporine/Tacrolimus), **T**ricyclic Antidepressants, **A**nti-epileptics (Phenytoin/Valproate), **D**igoxin, **A**minoglycosides, **T**heophylline" (**LITA DAT**). * **Drugs NOT requiring TDM:** Drugs with easily measurable physiological markers (e.g., Warfarin via PT/INR, Antihypertensives via Blood Pressure, Insulin via Blood Glucose). * **Phenytoin** is a classic "TDM favorite" in exams due to its non-linear pharmacokinetics.

Question 3: Which of the following therapeutic index (T.I.) values represents the greatest safety profile for a drug?

A. 100
B. 1,000 (Correct Answer)
C. 500
D. 2

Explanation: ### Explanation **Concept Overview** The **Therapeutic Index (T.I.)** is a quantitative measurement of a drug's relative safety [1]. It is defined as the ratio of the dose that produces toxicity to the dose that produces a clinically desired effective response. Mathematically, it is expressed as: **T.I. = TD₅₀ / ED₅₀** (or LD₅₀ / ED₅₀ in animal studies) [1] * **TD₅₀:** Toxic dose in 50% of the population. * **ED₅₀:** Effective dose in 50% of the population. **Why Option B is Correct** The safety of a drug is **directly proportional** to its Therapeutic Index [1]. A higher T.I. indicates a wider "margin of safety," meaning there is a large gap between the dose required for efficacy and the dose that causes toxicity [2]. Among the given options, **1,000** is the highest value, representing the widest margin and, therefore, the greatest safety profile. **Analysis of Incorrect Options** * **Options A (100) and C (500):** While these values represent relatively safe drugs, they are less safe than a drug with a T.I. of 1,000. * **Option D (2):** This represents a **Narrow Therapeutic Index (NTI)** drug. Such drugs are inherently risky because a small increase in dose or a minor change in blood concentration can lead to severe toxicity. **NEET-PG High-Yield Pearls** * **Narrow Therapeutic Index Drugs (Mnemonic: "W-A-R-F-I-N-G-L-E-T"):** **W**arfarin, **A**minoglycosides/Amiodarone, **R**ifampicin, **F**enytoin (Phenytoin), **I**nsulin, **N**eostigmine, **G**lycosides (Digoxin), **L**ithium, **E**thosuximide/Enalapril, **T**heophylline/Tricyclic Antidepressants. * **Clinical Monitoring:** Drugs with a low T.I. often require **Therapeutic Drug Monitoring (TDM)** to ensure safety and efficacy [3]. * **Penicillin** is a classic example of a drug with a very high T.I., making it remarkably safe even at high doses.

Question 4: All the following enzymes are involved in the metabolism of xenobiotics except?

A. Hydroxylase
B. Cytochrome oxidase (Correct Answer)
C. Cytochrome P450
D. Methylase

Explanation: **Explanation:** The metabolism of xenobiotics (foreign compounds) occurs primarily in the liver through Phase I (Functionalization) and Phase II (Conjugation) reactions. **Why Cytochrome Oxidase is the correct answer:** Cytochrome oxidase (also known as **Cytochrome c oxidase** or Complex IV) is a key enzyme in the **Electron Transport Chain** located in the inner mitochondrial membrane. Its primary role is cellular respiration—transferring electrons to oxygen to form water—rather than the detoxification of drugs. While it deals with oxygen, it is not involved in the metabolic transformation of xenobiotics. **Analysis of other options:** * **Cytochrome P450 (Option C):** This is the most important superfamily of enzymes involved in Phase I metabolism. They are hemoproteins located in the smooth endoplasmic reticulum that catalyze oxidative reactions for the majority of clinical drugs. * **Hydroxylase (Option A):** Hydroboxylation is a classic Phase I reaction. Many Cytochrome P450 enzymes function as mixed-function oxidases or hydroxylases, adding an –OH group to the substrate to make it more polar. * **Methylase (Option D):** Methylation is a specific type of Phase II conjugation reaction (e.g., COMT acting on catecholamines). It involves the transfer of a methyl group to the xenobiotic to alter its activity or facilitate excretion. **Clinical Pearls for NEET-PG:** * **Phase I reactions:** Oxidation (most common), Reduction, and Hydrolysis. * **Phase II reactions:** Glucuronidation (most common), Acetylation, Methylation, Sulfation, and Glutathione conjugation. * **Microsomal vs. Non-microsomal:** Cytochrome P450 and Glucuronosyltransferase are **microsomal** (located in the SER). Most other Phase II enzymes and non-P450 oxidative enzymes (like Alcohol Dehydrogenase) are **non-microsomal** (cytosolic or mitochondrial). * **Inducer vs. Inhibitor:** Remember that CYP3A4 is the most common isoform involved in drug metabolism. Drugs like Rifampicin induce these enzymes, while Ketoconazole inhibits them.

Question 5: Which of the following is an example of physiological antagonism?

A. Heparin–Protamine
B. Prostacycline–Thromboxane (Correct Answer)
C. Adrenaline–Phenoxybenzamine
D. Physostigmine–Acetylcholine

Explanation: ### Explanation **Physiological (Functional) Antagonism** occurs when two drugs act on **different receptors** or through different mechanisms, but produce **opposing physiological effects** on the same biological system. **1. Why Option B is Correct:** * **Prostacyclin (PGI2)** acts on IP receptors to cause vasodilation and inhibition of platelet aggregation. * **Thromboxane A2 (TXA2)** acts on TP receptors to cause vasoconstriction and promotion of platelet aggregation. * Since they produce opposite effects using distinct pathways/receptors, they are classic examples of physiological antagonists. **2. Analysis of Incorrect Options:** * **A. Heparin–Protamine:** This is an example of **Chemical Antagonism**. Protamine (strongly basic) reacts chemically with Heparin (strongly acidic) to form an inactive complex, neutralizing its effect without involving receptors. * **C. Adrenaline–Phenoxybenzamine:** This is **Pharmacological Antagonism**. Phenoxybenzamine is a non-competitive antagonist that binds to the same alpha-receptors that Adrenaline targets. * **D. Physostigmine–Acetylcholine:** This is **Synergism/Potentiation**. Physostigmine inhibits the enzyme acetylcholinesterase, preventing the breakdown of Acetylcholine, thereby increasing its concentration and effect. **3. NEET-PG High-Yield Pearls:** * **Most Common Example:** The most frequently asked example of physiological antagonism is **Adrenaline vs. Histamine** on bronchial smooth muscle (Adrenaline causes bronchodilation via $\beta_2$ receptors; Histamine causes bronchoconstriction via $H_1$ receptors). * **Glucagon vs. Insulin:** Another high-yield example (Glucagon increases blood sugar; Insulin decreases it). * **Key Distinction:** Unlike competitive antagonism, physiological antagonism cannot be completely overcome by increasing the dose of the agonist because the drugs work on entirely different systems.

Question 6: Sibutramine belongs to which group of drugs according to its indication of use?

A. Antipsychotic
B. Antihypertensive
C. Anti-Obesity (Correct Answer)
D. Anti-Diabetic

Explanation: ### Explanation **Correct Answer: C. Anti-Obesity** **Mechanism of Action:** Sibutramine is a centrally acting drug used for weight management. It functions as a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. By inhibiting the reuptake of these neurotransmitters in the hypothalamus, it enhances satiety (feeling of fullness) and increases metabolic rate (thermogenesis), thereby reducing food intake and promoting weight loss. **Analysis of Incorrect Options:** * **A. Antipsychotic:** Antipsychotics (like Haloperidol or Clozapine) primarily target Dopamine ($D_2$) receptors. Interestingly, many antipsychotics cause weight *gain* as a side effect, the opposite of Sibutramine’s effect. * **B. Antihypertensive:** Sibutramine is actually **contraindicated** in patients with uncontrolled hypertension because its sympathomimetic effects (increased norepinephrine) can elevate blood pressure and heart rate. * **D. Anti-Diabetic:** While weight loss can improve glycemic control in Type 2 Diabetes, Sibutramine does not have a direct mechanism for lowering blood glucose (unlike Metformin or GLP-1 agonists). **High-Yield Clinical Pearls for NEET-PG:** * **Regulatory Status:** Sibutramine was **withdrawn** from the market in many countries (including India and the USA) due to the **SCOUT trial**, which showed an increased risk of major adverse cardiovascular events (MI and stroke). * **Drug Class:** It is chemically related to amphetamines but does not have the same high potential for abuse. * **Other Anti-Obesity Drugs to Remember:** * **Orlistat:** Gastric and pancreatic lipase inhibitor (prevents fat absorption). * **Lorcaserin:** $5HT_{2C}$ receptor agonist (withdrawn due to cancer risk). * **Liraglutide:** GLP-1 receptor agonist (injectable). * **Phentermine + Topiramate:** Combination therapy.

Question 7: Which of the following drugs can cause malignant hyperthermia?

A. Succinylcholine
B. Halothane
C. Lidocaine
D. All the above (Correct Answer)

Explanation: **Explanation:** **Malignant Hyperthermia (MH)** is a rare, life-threatening pharmacogenetic disorder of skeletal muscle characterized by a hypermetabolic state. It is primarily caused by an inherited mutation in the **Ryanodine Receptor (RYR1)** or the dihydropyridine receptor, leading to excessive calcium release from the sarcoplasmic reticulum. **Why "All the above" is correct:** * **Succinylcholine (Option A):** This depolarizing neuromuscular blocker is a classic "triggering agent." It causes persistent depolarization, which, in susceptible individuals, leads to massive calcium release and muscle rigidity. * **Halothane (Option B):** All volatile inhalational anesthetics (Halothane, Isoflurane, Sevoflurane, etc.) are potent triggers of MH. Halothane is historically the most frequently implicated agent in textbooks. * **Lidocaine (Option C):** While modern amide locals are generally considered safe, classic pharmacological teaching and older literature have associated high doses of amide local anesthetics with triggering or exacerbating MH. In the context of this specific MCQ, it is included as a potential trigger alongside the primary culprits. **Clinical Pearls for NEET-PG:** 1. **Early Sign:** The earliest and most reliable sign of MH is an **increase in End-Tidal CO2 (ETCO2)**, followed by tachycardia and masseter muscle rigidity. 2. **Late Sign:** Hyperthermia (fever) is often a late sign but can be extreme (>42°C). 3. **Drug of Choice:** **Dantrolene** is the specific antidote. It works by blocking the Ryanodine receptors (RYR1), thereby inhibiting calcium release. 4. **Safe Agents:** Safe alternatives for MH-susceptible patients include Propofol, Etomidate, Ketamine, and Ester-type local anesthetics.

Question 8: Zero order kinetics is followed by all of the following drugs EXCEPT?

A. Phenytoin
B. Barbiturates (Correct Answer)
C. Alcohol
D. Theophylline

Explanation: The core concept here is the difference between **First-order** and **Zero-order kinetics**. Most drugs follow first-order kinetics, where a constant *fraction* of the drug is eliminated per unit time [1]. In contrast, zero-order kinetics occurs when the elimination processes (usually enzymes) become saturated; a constant *amount* of the drug is eliminated regardless of its plasma concentration [1]. **1. Why Barbiturates is the correct answer:** Most **Barbiturates** (like Phenobarbital) follow **First-order kinetics**. Their rate of elimination is proportional to the plasma concentration [1]. While very high doses can lead to saturation, they are classically categorized as first-order drugs in standard pharmacological teaching. **2. Analysis of Incorrect Options (Drugs following Zero-order kinetics):** * **Phenytoin (A):** It follows zero-order kinetics at therapeutic or high concentrations (Michaelis-Menten kinetics). Small dose increases can lead to disproportionately large increases in plasma levels, causing toxicity [1]. * **Alcohol/Ethanol (C):** It is the classic example of zero-order kinetics. The enzyme alcohol dehydrogenase is saturated even at low social drinking levels [1]. * **Theophylline (D):** At higher therapeutic ranges, theophylline's metabolism becomes saturated, shifting from first-order to zero-order kinetics. **3. High-Yield Clinical Pearls for NEET-PG:** To remember the drugs following Zero-order kinetics, use the mnemonic **"WATT"** or **"Zero WATTS"**: * **W** – Warfarin (at very high doses) * **A** – Alcohol / Aspirin (at high doses) * **T** – Theophylline * **T** – Tolbutamide * **S** – Salicylates / **S**-Phenytoin **Key distinction:** Zero-order kinetics is also called **"Capacity-limited elimination"** or **"Non-linear kinetics."** In these drugs, the half-life ($t_{1/2}$) is not constant; it increases as the dose increases [1].

Question 9: All of the following are inducers of the microsomal enzyme system except?

A. Carbamazepine
B. Phenytoin
C. Phenobarbitone
D. Ticlopidine (Correct Answer)

Explanation: ### Explanation The microsomal enzyme system, primarily the **Cytochrome P450 (CYP450)** family in the liver, is responsible for the metabolism of many drugs. **Enzyme Inducers** increase the synthesis of these enzymes, leading to faster metabolism and decreased plasma concentrations of co-administered drugs. **Why Ticlopidine is the Correct Answer:** Ticlopidine is an antiplatelet drug that acts as a **microsomal enzyme inhibitor**, specifically inhibiting CYP2C19. Unlike inducers, inhibitors decrease enzyme activity, which can lead to toxic levels of other drugs (e.g., phenytoin or theophylline) if administered concurrently. **Analysis of Incorrect Options (Inducers):** * **A. Carbamazepine:** A potent inducer of CYP3A4. It is unique because it is an **auto-inducer**, meaning it induces its own metabolism over time. * **B. Phenytoin:** A classic broad-spectrum inducer that affects multiple CYP isoforms, often leading to significant drug-drug interactions (e.g., reducing the efficacy of oral contraceptives). * **C. Phenobarbitone:** One of the most powerful known inducers. It increases the synthesis of glucuronyl transferase and CYP enzymes, and is clinically used in neonatal jaundice to accelerate bilirubin conjugation. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Mnemonic for Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**iclopidine/Terfenadine, **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**on-DHP CCBs (Verapamil/Diltiazem), **K**etoconazole (and other Azoles). * **Chronic Alcoholism** induces enzymes, whereas **Acute Alcohol intake** inhibits them. * **St. John’s Wort** is a notable herbal enzyme inducer often tested in exams.

Question 10: Which drug schedule requires medical supervision for its administration?

A. Schedule H
B. Schedule G (Correct Answer)
C. Schedule M
D. Schedule P

Explanation: The correct answer is **Schedule G**. In the context of the Drugs and Cosmetics Act (1940), different schedules categorize drugs based on their storage, sale, and administration requirements [1, 2]. **Why Schedule G is correct:** Schedule G contains a list of drugs that are mostly used for chronic conditions and require **medical supervision** during their administration. These drugs are not necessarily "dangerous" in the same way as narcotics, but they carry risks that necessitate monitoring by a physician. Labels for these drugs must carry the mandatory warning: "Caution: It is dangerous to take this preparation except under medical supervision." Common examples include Metformin, Glibenclamide, and various antihistamines. **Analysis of Incorrect Options:** * **Schedule H:** These are **Prescription Drugs**. They can only be sold by retail on the prescription of a Registered Medical Practitioner (RMP) [1, 2]. While they require a prescription, they do not specifically mandate "medical supervision" during the actual course of administration. * **Schedule M:** This relates to **Good Manufacturing Practices (GMP)**. It outlines the requirements for factory premises, waste disposal, and equipment for pharmaceutical companies. * **Schedule P:** This specifies the **Life period (expiry date)** and storage conditions for various drugs. **High-Yield Clinical Pearls for NEET-PG:** * **Schedule X:** Includes Psychotropic drugs and Narcotics (e.g., Ketamine, Amphetamines). These require a double-copy prescription, and the pharmacist must preserve the prescription for 2 years [1, 2]. * **Schedule Y:** Guidelines for **Clinical Trials** and import/manufacture of new drugs. * **Schedule K:** List of drugs exempted from certain provisions of manufacture.

Practice by Chapter

Pharmacokinetics: Absorption and Distribution

Practice Questions

Pharmacokinetics: Metabolism and Excretion

Practice Questions

Pharmacodynamics and Receptor Theory

Practice Questions

Drug-Receptor Interactions and Dose-Response

Practice Questions

Pharmacogenetics and Personalized Medicine

Practice Questions

Adverse Drug Reactions and Toxicity

Practice Questions

Drug Interactions

Practice Questions

Drug Development and Regulation

Practice Questions

Pediatric and Geriatric Pharmacology

Practice Questions

Placental Transfer and Lactation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free